================================================================================
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or 240.14a-12
CirTran Corporation
--------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement If Other Than The Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required
[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or
Item 22(a)(2) of Schedule 14A.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
-------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
-------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee
is calculated and state how it was determined):
--------------------------
4) Proposed maximum aggregate value of transaction:
-------------------------------------------------------------------------
5) Total fee paid:
-------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form of Schedule and the date of its filing.
1) Amount Previously Paid: _________________________________________________
2) Form, Schedule or Registration Statement No _____________________________
3) Filing Party: ___________________________________________________________
4) Date Filed: _____________________________________________________________
================================================================================
CirTran Corporation
4125 South 6000 West
West Valley City, Utah 84128
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
TO BE HELD APRIL 30, 2007
To the Shareholders:
Notice is hereby given that a Special Meeting of the Shareholders of
CirTran Corporation (the "Company") will be held at the Company's headquarters,
located at 4125 South 6000 West, West Valley City, Utah 84128, on Monday, April
30, 2007, at 10:00 a.m., M.D.S.T., for the following purpose, which is discussed
in the following pages and which are made part of this Notice:
1. To consider and act upon a proposed amendment to the Company's
articles of incorporation that increases the authorized capital of
the Company to include 1,500,000,000 shares of common stock and
effectuates a 1.2 shares for one share forward stock split; and
2. To consider and act upon any other matters that properly may come
before the meeting or any adjournment thereof.
The Company's Board of Directors has fixed the close of business on
Friday, March 16, 2007, as the record date (the "Record Date") for the
determination of shareholders having the right to notice of, and to vote at, the
Special Meeting of Shareholders and any adjournment thereof. A list of such
shareholders will be available for examination by a shareholder for any purpose
germane to the meeting during ordinary business hours at the offices of the
Company at 4125 South 6000 West, West Valley City, Utah, 84128, during the ten
business days prior to the meeting.
You are requested to date, sign and return the enclosed proxy which is
solicited by the Board of Directors of the Company and will be voted as
indicated in the accompanying proxy statement and proxy. Your vote is important.
Please sign and date the enclosed Proxy and return it promptly, either in the
enclosed return envelope or by facsimile to (801) 277-3147, whether or not you
expect to attend the meeting. The giving of your proxy as requested hereby will
not affect your right to vote in person should you decide to attend the Special
Meeting. The return envelope requires no postage if mailed in the United States.
If mailed elsewhere, foreign postage must be affixed. Your proxy is revocable at
any time before the meeting.
By Order of the Board of Directors,
/s/ Iehab Hawatmeh
West Valley City, Utah
March 29, 2007 Iehab Hawatmeh,
President and Director
CirTran Corporation
4125 South 6000 West
West Valley City, Utah 84128
(801) 963-5112
----------------------------------------
PROXY STATEMENT
----------------------------------------
SPECIAL MEETING OF SHAREHOLDERS
The enclosed proxy is solicited by the Board of Directors of CirTran Corporation
("CirTran" or the "Company") for use in voting at the Special Meeting of
Shareholders (the "Special Meeting") to be held at the Company's headquarters,
located at 4125 South 6000 West, West Valley City, Utah 84128, on Monday, April
30, 2007, at 10:00 a.m., M.D.T., and at any postponement or adjournment thereof,
for the purposes set forth in the attached notice. When proxies are properly
dated, executed and returned, the shares they represent will be voted at the
Special Meeting in accordance with the instructions of the shareholder
completing the proxy. If a signed proxy is returned but no specific instructions
are given, the shares will be voted (i) FOR approval of a proposed amendment to
the Company's articles of incorporation that would increase the authorized
capital of the Company to include 1,500,000,000 shares of common stock and the
1.2 shares for one share forward stock split. A shareholder giving a proxy has
the power to revoke it at any time prior to its exercise by voting in person at
the Special Meeting, by giving written notice to the Company's Secretary prior
to the Special Meeting or by giving a later dated proxy.
The presence at the meeting, in person or by proxy, of shareholders holding in
the aggregate a majority of the outstanding shares of the Company's common stock
entitled to vote shall constitute a quorum for the transaction of business. Each
share present at the meeting in person or by proxy is entitled to one vote on
each matter presented at the meeting. A majority of votes properly cast upon any
question presented for consideration and shareholder action at the meeting shall
decide the question. Abstentions and broker non-votes will count for purposes of
establishing a quorum, but will not count as votes cast for any questions and
accordingly will have no effect. Votes cast by shareholders who attend and vote
in person or by proxy at the Special Meeting will be counted by inspectors to be
appointed by the Company. (The Company anticipates that the inspectors will be
employees, attorneys or agents of the Company.)
The close of business on Friday, March 16, 2007, has been fixed as the record
date (the "Record Date") for determining the shareholders entitled to notice of,
and to vote at, the Special Meeting. Each share shall be entitled to one vote on
all matters. As of the Record Date there were 673,608,154 shares of the
Company's Class A common stock outstanding and entitled to vote, held by 525
holders of record. For a description of the principal holders of such stock, see
"SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT" below.
This Proxy Statement and the enclosed Proxy are being furnished to shareholders
on or about April 5, 2007.
----------------------------------------
-3-
PROPOSAL 1 - AMENDMENT OF ARTICLES OF INCORPORATION
As of January 1, 2007, the first paragraph of Article IV of the
Company's Articles of Incorporation, as amended to date, read:
"FOUR: The aggregate number of shares which this Corporation shall
have authority to issue is 750,000,000 Common Shares having a par
value of $0.001 per share. Each share of stock shall entitle the
holder thereof to one (1) vote on each matter submitted to a vote
at a meeting of the shareholders. All stock of the Corporation
shall be of the same class and shall have the same rights and
preferences. The capital stock of the Corporation shall be issued
as fully paid, and the private property of the shareholders shall
not be liable for the debts, obligations or liabilities of the
Corporation. Fully paid stock of this Corporation shall not be
liable to any further call of assessment. On May 19, 2000, the
shareholders of the Corporation approved a one for three thousand
(3,000) reverse stock split of the issued and outstanding shares
of the Corporation.
The Company's Board of Directors has approved the adoption of the
amendment (the "Amendment") to the Articles of Incorporation, and has
recommended the Amendment to the shareholders for their approval and adoption.
If approved by the shareholders of the Company at the Special Meeting,
the new first paragraph of Article IV of the Certificate of Incorporation, as
amended, would read as follows:
ARTICLE IV
CAPITALIZATION
The aggregate number of shares which this Corporation shall have
authority to issue is 1,500,000,000 Common Shares having a par
value of $0.001 per share. Each share of stock shall entitle the
holder thereof to one (1) vote on each matter submitted to a vote
at a meeting of the shareholders. All stock of the Corporation
shall be of the same class and shall have the same rights and
preferences. The capital stock of the Corporation shall be issued
as fully paid, and the private property of the shareholders shall
not be liable for the debts, obligations or liabilities of the
Corporation. Fully paid stock of this Corporation shall not be
liable to any further call of assessment. Effective as of the time
at which this Certificate of Amendment to Articles of
Incorporation (the "Amended Articles") becomes effective (the
"Effective Date"), all outstanding shares of common stock of the
Corporation automatically shall be subdivided at the rate of 1.20
shares for one share (the "Forward Split") without the necessity
of any further action on the part of the holders thereof or the
Corporation, provided, however, that the Corporation shall,
through its transfer agent and as necessary, exchange certificates
representing common stock outstanding immediately prior to the
Effective Date of the Forward Split (the "Existing Common") into
new certificates representing the appropriate number of shares of
common stock resulting from the subdivision ("New Common").
Except for this change, the amendment would not affect any other
provision of the Articles of Incorporation. The text of the proposed amendment
to amend Article IV to the Articles of Incorporation is attached to this Proxy
Statement Statement as Exhibit 1 and is incorporated herein by reference.
Background of the Proposed Amendment
Increase in Authorized Capital
------------------------------
As of January 1, 2007, we were authorized, pursuant to our Articles of
Incorporation, as amended to date, to issue up to 750,000,000 shares of our
common stock, and there were 655,716,326 shares of the Company's Common Stock
issued and outstanding. Additionally, as of the Record Date, the Company had the
following obligations to reserve or issue shares of its common stock:
-4-
The Highgate Convertible Debenture Transaction
On May 26, 2005, we entered into a securities purchase agreement (the
"Purchase Agreement") with Highgate House Funds, Ltd., a Cayman Island exempted
company ("Highgate"), relating to the issuance by us of a 5% Secured Convertible
Debenture, due December 31, 2007, in the aggregate principal amount of
$3,750,000 (the "Highgate Debenture").
In connection with the purchase of the Highgate Debenture, we used
$2,265,000 to repay two promissory notes to Cornell Capital Partners, LP
("Cornell"), one in the amount of $1,700,000, and the other in the amount of
$565,000. Highgate and Cornell have the same general partner, Yorkville
Advisors, but have different portfolio managers.
We also paid a commitment fee of $240,765, a structuring fee of $10,000
to Highgate, and legal fees of $5,668. As such, of the total purchase amount of
$3,750,000, the net proceeds to us were $1,228,567, which we received following
the closing of the issuance of the Highgate Debenture. We used these proceeds
for general corporate and working capital purposes.
The Highgate Debenture bears interest at a rate of 5%. Highgate is
entitled to convert, at its option, all or part of the principal amount owing
under the Highgate Debenture into shares of our common stock at a conversion
price equal to the lesser of (a) $0.10 per share, or (b) an amount equal to the
lowest closing bid price of the Common Stock as listed on the OTC Bulletin
Board, as quoted by Bloomberg L.P. for the twenty (20) trading days immediately
preceding the conversion date. Except as otherwise set forth in the Highgate
Debenture, Highgate's right to convert principal amounts owing under the
Highgate Debenture into shares of our common stock is limited as follows:
1. Highgate may convert up to $250,000 worth of the principal amount
plus accrued interest of the Highgate Debenture in any consecutive
30-day period when the market price of our stock is $0.10 per
share or less at the time of conversion;
2. Highgate may convert up to $500,000 worth of the principal amount
plus accrued interest of the Highgate Debenture in any consecutive
30-day period when the price of our stock is greater than $0.10
per share at the time of conversion, provided, however, that
Highgate may convert in excess of the foregoing amounts if we and
Highgate mutually agree; and
3. Upon the occurrence of an event of default (as defined in the
Highgate Debenture), Highgate may, in its sole discretion,
accelerate full repayment of all debentures outstanding and
accrued interest thereon or may, notwithstanding any limitations
contained in the Highgate Debenture and/or the Purchase Agreement,
convert the Highgate Debenture and accrued interest thereon into
shares of our common stock pursuant to the Highgate Debenture.
Pursuant to the Highgate Debenture, interest is to be paid at the time
of maturity or conversion. We may, at our option, pay accrued interest in cash
or in shares of common stock. If paid in stock, the conversion price shall be
the closing bid price of the common stock on either (i) the date the interest
payment is due; or (ii) if the interest payment is not made when due, the date
on which the interest payment is made.
As noted above, assuming a hypothetical conversion of the $2,650,000
remaining as of January 29, 2007, at a hypothetical conversion price of $0.02
per share, we would need to issue 132,500,000 shares of our common stock to
Highgate. Please note that if the conversion price changes, the number of shares
issuable on conversion also changes. We have included a table below with
examples of the number of shares issuable at various conversion prices.
-5-
The 2005 Cornell Convertible Debenture Transaction
On December 30, 2005, we entered into a securities purchase agreement
(the "Cornell Purchase Agreement") with Cornell Capital Partners, a Delaware
limited partnership ("Cornell Capital"), relating to the issuance by us of a 5%
Secured Convertible Debenture, due July 30, 2008, in the aggregate principal
amount of $1,500,000 (the "Cornell Debenture").
We also paid a commitment fee of $120,000, and a structuring fee of
$10,000 to Cornell Capital. As such, of the total purchase amount of $1,500,000,
the net proceeds to us were $1,370,000.
The Cornell Debenture bears interest at a rate of 5%. Cornell Capital
is entitled to convert, at its option, all or part of the principal amount owing
under the Debenture into shares of the Company's common stock at a conversion
price equal one hundred percent (100%) of the lowest closing bid price of the
Common Stock as listed on the OTC Bulletin Board, as quoted by Bloomberg L.P.
for the twenty (20) trading days immediately preceding the Conversion Date,
subject to certain restrictions and limitations set forth in the Cornell
Debenture.
Under the terms of the Cornell Debenture, except upon an event of
default as defined in the Cornell Debenture, Cornell Capital may not convert the
Cornell Debenture for a number of shares of common stock in excess of that
number of shares of common stock which, upon giving effect to such conversion,
would cause the aggregate number of shares of Common Stock beneficially owned by
Cornell Capital and its affiliates to exceed 4.99% of the outstanding shares of
the common stock following such conversion.
Pursuant to the Cornell Debenture, interest is to be paid at the time
of maturity or conversion. We may, at our option, pay accrued interest in cash
or in shares of our common stock. If paid in stock, the conversion price shall
be the closing bid price of the common stock on either (i) the date the interest
payment is due; or (ii) if the interest payment is not made when due, the date
on which the interest payment is made.
In connection with the Cornell Purchase Agreement, we also agreed to
grant to Cornell Capital warrants (the "Cornell Warrants") to purchase up to an
additional 10,000,000 shares of our common stock. The Cornell Warrants have an
exercise price of $0.09 per share, and expire three years from the date of
issuance. The Cornell Warrants also provide for cashless exercise if at the time
of exercise there is not an effective registration statement or if an event of
default has occurred.
As noted above, assuming a hypothetical conversion of the $1,500,000
remaining as of January 29, 2007, at a hypothetical conversion price of $0.02
per share, we would need to issue 75,000,000 shares of our common stock to
Cornell. Please note that if the conversion price changes, the number of shares
issuable on conversion also changes. We have included a table below with
examples of the number of shares issuable at various conversion prices.
The 2006 Cornell Convertible Debenture Transaction
On August 23, 2006, we entered into a securities purchase agreement
(the "2006 Cornell Purchase Agreement") with Cornell relating to the issuance by
us of another 5% Secured Convertible Debenture, due April 23, 2009, in the
aggregate principal amount of $1,500,000 (the "2006 Cornell Debenture").
We also paid a commitment fee of $120,000, and a structuring fee of
$15,000 to Cornell. As such, of the total purchase amount of $1,500,000, the net
proceeds to us were $1,365,000.
The 2006 Cornell Debenture bears interest at a rate of 5%. Cornell is
entitled to convert, at its option, all or part of the principal amount owing
under the 2006 Cornell Debenture into shares of the Company's common stock at a
conversion price equal one hundred percent (100%) of the lowest closing bid
price of the Common Stock as listed on the OTC Bulletin Board, as quoted by
Bloomberg L.P. for the twenty (20) trading days immediately preceding the
Conversion Date, subject to certain restrictions and limitations set forth in
the 2006 Cornell Debenture.
Under the terms of the 2006 Cornell Debenture, except upon an event of
default as defined in the 2006 Cornell Debenture, Cornell may not convert the
Cornell Debenture for a number of shares of common stock in excess of that
-6-
number of shares of common stock which, upon giving effect to such conversion,
would cause the aggregate number of shares of Common Stock beneficially owned by
Cornell and its affiliates to exceed 4.99% of the outstanding shares of the
common stock following such conversion.
Pursuant to the 2006 Cornell Debenture, interest is to be paid at the
time of maturity or conversion. We may, at our option, pay accrued interest in
cash or in shares of our common stock. If paid in stock, the conversion price
shall be the closing bid price of the common stock on either (i) the date the
interest payment is due; or (ii) if the interest payment is not made when due,
the date on which the interest payment is made.
In connection with the 2006 Cornell Purchase Agreement, we also agreed
to grant to Cornell warrants (the "2006 Cornell Warrants") to purchase up to an
additional 15,000,000 shares of our common stock. The 2006 Cornell Warrants have
an exercise price of $0.06 per share, and expire three years from the date of
issuance. The 2006 Cornell Warrants also provide for cashless exercise if at the
time of exercise there is not an effective registration statement or if an event
of default has occurred.
As noted above, assuming a hypothetical conversion of the $1,500,000
remaining under the 2006 Cornell Debenture, as of January 29, 2007, at a
hypothetical conversion price of $0.02 per share, we would need to issue
75,000,000 shares of our common stock to Cornell. Please note that if the
conversion price changes, the number of shares issuable on conversion also
changes. The Cornell Debenture (issued in December 2005) and the 2006 Cornell
Debenture are referred to collectively as the "Cornell Debentures."
We have included a table below with examples of the number of shares
issuable at various conversion prices.
Highgate and Cornell have the same general partner, Yorkville Advisors,
but have different portfolio managers. Additionally, the escrow agent appointed
in connection with the purchase and sale of both the Cornell debenture
transactions and the Highgate debenture transaction is David Gonzalez, who is an
officer of Cornell.
A chart showing the number of shares issuable upon hypothetical
conversions of the Highgate Debenture and the Cornell Debentures at particular
conversion prices is as follows:
Holders of CirTran common stock are subject to the risk of additional and
substantial dilution to their interests as a result of the issuances of common
stock in connection with the Convertible Debentures.
The following table describes the number of shares of common stock that
would be issuable, assuming that the full principal amount of the Cornell
Debentures and the Highgate Debentures (collectively, the "Convertible
Debentures"), excluding any interest accrued, was converted into shares of our
common stock, irrespective of the availability of registered shares and any
conversion limitations contained in the Convertible Debentures, and further
assuming that the applicable conversion or exercise prices at the time of such
conversion or exercise were the following amounts:
--------------------------------------------------------------------------------
Shares Issuable Total Shares
Upon Conversion Issuable in
Shares Issuable Upon of $3,000,000 Connection with
Conversion of Principal Amount Conversion of
$2,650,000 Principal of Convertible Aggregate Principal
Hypothetical Amount of Convertible Debentures by Amount of
Conversion Debenture by Highgate Cornell Capital Convertible
Price House Funds, Ltd. Partners Debentures
------------ --------------------- ---------------- -------------------
$0.01 265,000,000 300,000,000 565,000,000
------------ --------------------- ---------------- -------------------
$0.02 132,500,000 150,000,000 282,500,000
------------ --------------------- ---------------- -------------------
$0.03 88,333,333 100,000,000 183,333,333
------------ --------------------- ---------------- -------------------
$0.04 66,250,000 75,000,000 141,250,000
------------ --------------------- ---------------- -------------------
$0.05 53,000,000 60,000,000 113,000,000
------------ --------------------- ---------------- -------------------
$0.10 26,500,000 30,000,000 56,500,000
--------------------------------------------------------------------------------
-7-
Given the formula for calculating the shares to be issued in connection
with conversions of the Convertible Debentures, there effectively is no
limitation on the number of shares of common stock which may be issued in
connection with conversions of the Convertible Debentures, except for the number
of shares registered under prospectuses and related registration statements. As
such, holders of our common stock may experience substantial dilution of their
interests to the extent that Highgate and/or Cornell converts amounts under the
Convertible Debentures.
Although we have entered into an agreement with Cornell wherein Cornell
agreed that it would not convert any of the principal or interest on the Cornell
Debentures or exercise any of the Warrants granted to Cornell until we had taken
the steps necessary to increase our authorized capital, if we are successful in
increasing our authorized capital, Cornell will be able to convert the Cornell
Debentures pursuant to its terms, which could result in the dilution described
above.
ANAHOP Private Placement Transactions
On May 24, 2006, we closed a private placement of shares of our common
stock and warrants (the "May Private Offering"). Pursuant to a securities
purchase agreement (the "Agreement"), we sold Fourteen Million, Two Hundred
Eighty-five Thousand, Seven Hundred Fifteen (14,285,715) shares of our Common
Stock (the "Shares") to ANAHOP, Inc., a California corporation ("ANAHOP"). The
consideration paid for the Shares was One Million Dollars ($1,000,000). There
were no underwriting discounts. In addition to the Shares, we issued warrants
(the "May Warrants") to designees of ANAHOP as follows:
- A warrant to purchase up to 10,000,000 shares, with an exercise
price of $0.15 per share, exercisable upon the date of issuance,
to Albert Hagar.
- A warrant to purchase up to 5,000,000 shares, with an exercise
price of $0.15 per share, exercisable upon the date of issuance,
to Fadi Nora.
- A warrant to purchase up to 5,000,000 shares, with an exercise
price of $0.25 per share, exercisable upon the date of issuance,
to Fadi Nora.
- A warrant to purchase up to 10,000,000 shares, with an exercise
price of $0.50 per share, to Albert Hagar.
The May Warrants have exercise prices ranging from $0.15 to $0.50 as
noted above, and are exercisable as of the date of issuance and through and
including the date which is five years following the date on which our Common
Stock is listed for trading on either the Nasdaq Small Cap Market, the Nasdaq
Capital Market, the American Stock Exchange, or the New York Stock Exchange (the
"Expiration Date").
On June 30, 2006, we closed a second private placement of shares of our
common stock and warrants (the "June Private Offering"). Pursuant to a
securities purchase agreement (the "June Agreement"), the Company agreed to sell
Twenty-Eight Million, Five Hundred Seventy-One Thousand, Four Hundred
Twenty-Eight (28,571,428) shares of its Common Stock (the "June Shares") to
ANAHOP. The total consideration to be paid for the Shares will be Two Million
Dollars ($2,000,000) if all tranches of the sale close.
Pursuant to the Agreement, ANAHOP agreed to pay Three Hundred Thousand
Dollars ($300,000) at the time of closing, and an additional Two Hundred
Thousand Dollars ($200,000) within 30 days of the closing. (The payments of
$300,000 and $200,000 are referred to collectively as the "First Tranche
Payment.") Upon the receipt of the First Tranche Payment, we agreed to issue a
certificate or certificates to the Purchaser representing 7,142,857 of the
Shares. The 7,142,857 shares were issued in July 2006.
The remaining $1,500,000 is to be paid by ANAHOP as follows:
(i) No later than thirty calendar days following the date on
which any class of our capital stock is first listed for
trading on either the Nasdaq Small Cap Market, the Nasdaq
-8-
Capital Market, the American Stock Exchange, or the New
York Stock Exchange, ANAHOP agreed to pay an additional
$500,000 to us; and
(ii) No later than sixty calendar days following the date on
which any class of our capital stock is first listed for
trading on either the Nasdaq Small Cap Market, the Nasdaq
Capital Market, the American Stock Exchange, or the New
York Stock Exchange, ANAHOP agreed to pay an additional
$1,000,000 to us. (The payments of $500,000 and $1,000,000
are referred to collectively as the "Second Tranche
Payment.")
Upon receipt by us of the Second Tranche Payment, we agreed to
issue a certificate or certificates to ANAHOP representing the remaining
21,428,571 Shares. Additionally, once we have received the Second Tranche
Payment, we agreed to issue warrants (the "June Warrants") to designees of the
Purchaser as follows:
- A warrant to purchase up to 20,000,000 shares, with an
exercise price of $0.15 per share, exercisable upon the
date of issuance, to Albert Hagar.
- A warrant to purchase up to 10,000,000 shares, with an
exercise price of $0.15 per share, to Fadi Nora.
- A warrant to purchase up to 10,000,000 shares, with an
exercise price of $0.25 per share, exercisable upon the
date of issuance, to Fadi Nora.
- A warrant to purchase up to 23,000,000 shares, with an
exercise price of $0.50 per share, exercisable upon the
date of issuance, to Albert Hagar.
The June Warrants have exercise prices ranging from $0.15 to $0.50 as
noted above, and are exercisable as of the date of issuance and through and
including the later of (1) the fifth anniversary of the date of the June Warrant
or (2) the fifth anniversary of the date on which our Common Stock is first
listed for trading on either the Nasdaq Small Cap Market, the Nasdaq Capital
Market, the American Stock Exchange, or the New York Stock Exchange (the
"Expiration Date").
Warrants
The 110,000,000 Warrants which the Company had outstanding as of the
Record Date, consisted of:
- 30,000,000 May Warrants issued in connection with the May Private
Offering;
- 63,000,000 June Warrants issued in connection with the June
Private Offering;
- 25,000,000 Warrants issued to Cornell in connection with the
Cornell Debentures; and
- 7,000,000 Warrants held by other holders.
There is no guarantee that any or all of these warrants will be
exercised, or that we will be required to issue any shares of common stock in
connection with these warrants. However, until such time as the warrants listed
above have expired, we will continue to reserve shares for issuance in
connection with the warrants.
Options
We also have outstanding options to purchase up to 11,250,500 shares of
our common stock, held by various holders. As with the warrants, there is no
guarantee that any or all of these options will be exercised, or that we will be
required to issue any shares of common stock in connection with these options.
However, until such time as these options have expired, we will continue to
reserve shares for issuance in connection with the options.
-9-
We do not have any lock-down or other agreements with the option
holders regarding the non-exercise of these options.
In summary, and assuming a hypothetical conversion of the Convertible
Debentures at the market price as of the Record Date, which was approximately
$0.02, the Company has the obligation or anticipation of issuing the following
shares:
-------------------------------------------------------------------
Convertible Debentures 282,500,000
-------------------------------------------------------------------
Warrants 125,000,000
-------------------------------------------------------------------
ANAHOP Second Tranche Shares 21,428,571
-------------------------------------------------------------------
Options 11,250,000
-------------------------------------------------------------------
-------------------------------------------------------------------
TOTAL 440,178,571
-------------------------------------------------------------------
In light of the Company's current authorized capital, and in light of
the share obligations listed in the table above, Management believes that the
proposed amendment to increase the Company's authorized capital would benefit
the Company by:
- enabling the Company to meet its obligations set forth above;
- allowing the Board of Directors to issue additional equity
securities to raise additional capital;
- allowing the Board of Directors to pursue strategic investment and
technology partners;
- allowing the Board of Directors to facilitate possible future
acquisitions; and
- allowing the Company to provide stock-related employee benefits.
As of the date of the Proxy Statement, the Company's primary source of
financing has been private sales of Common Stock or other equity securities,
such as the prior equity line of credit and the ANAHOP private transaction, as
well as debt securities convertible into Common Stock, such as the current
Convertible Debentures. To facilitate additional similar financing transactions,
the authorized capital of the Company will need to be increased pursuant to a
shareholder-approved amendment to the certificate of incorporation.
As of the date of this Proxy Statement, and other than the Company's
existing obligations and commitments to reserve and issue shares as described
herein, the Company did not have any plans, arrangements, commitments, or
understandings for the issuance of additional shares of the common stock which
are proposed to be authorized. Nevertheless, the Board of Directors believes
that the increase in the Company's authorized capital is necessary both to meet
the Company's present commitments, and to facilitate additional future financing
transactions should they become necessary.
For these reasons, the Company's Board of Directors has sought
shareholder approval of the proposed amendment.
Depending upon the consideration per share received by the Company for
any subsequent issuance of Common Stock, such issuance could have a dilutive
effect on those shareholders who previously paid a higher consideration per
share for their stock. Also, future issuances of Common Stock will increase the
number of outstanding shares, thereby decreasing the percentage ownership in the
Company (for voting, distributions and all other purposes) represented by
existing shares of Common Stock. The availability for issuance of the additional
shares of Common Stock may be viewed as having the effect of discouraging an
unsolicited attempt by another person or entity to acquire control of the
Company. Although the Board of Directors has no present intention of doing so,
the Company's authorized but unissued Common Stock could be issued in one or
more transactions that would make a takeover of the Company more difficult or
costly, and therefore less likely. The Company is not aware of any person or
entity who is seeking to acquire control of the Company. Holders of Common Stock
do not have any preemptive rights to acquire any additional securities issued by
the Company.
-10-
Forward Stock Split
-------------------
The Amendment, if approved by the shareholders of the Company, would
also effectuate a forward stock split (the "Stock Split") on a ratio of 1.20 new
shares (the "New Shares") for each one share of the Company's common stock (the
"Old Shares").
The Board of Directors has determined that it will be advantageous to
the Company to have additional shares available and issued to the Company's
current shareholders. Additionally, the Board has determined that share
liquidity could be enhanced by having additional shares held by the Company's
shareholders. Moreover, the Company feels that the Stock Split likely would be
beneficial to the Company's shareholders.
EFFECTIVE DATE
The Amendment to our Articles of Incorporation, as amended to date, to
increase in our authorized capital from 750,000,000 shares of common stock to
1,500,000,000 shares of common stock and to effectuate the stock split has been
approved by Company's Board of Directors and recommended to the Company's
shareholders for approval and adoption at the Special Meeting. If at the Special
Meeting shareholders holding sufficient shares to authorize such Amendment vote
to approve and adopt the Amendment, the Company anticipates that it will file,
within one business day of such approval, the Articles of Amendment with the
Nevada Secretary of State. The Articles of Amendment will become effective upon
filing the Articles of Amendment with the Nevada Secretary of State. We
anticipate that we will file the Articles of Amendment on May 1, 2007, which is
the day following the Special Meeting.
The shareholders of record of the Company's common stock as of May 10,
2007, will receive the benefit of the Stock Split. As soon as practicable after
the Effective Date of the Articles of Amendment, the Company's stockholders as
of May 10, will be notified that the Stock Split has been effected. The Company
expects that its transfer agent, Interwest Transfer Company, will act as
exchange agent for purposes of implementing the exchange of stock certificates.
Holders of Old Shares will be asked to surrender to the exchange agent
certificates representing Old Shares in exchange for certificates representing
New Shares in accordance with the procedures to be set forth in the letter of
transmittal the Company sends to its stockholders. No new certificates will be
issued to a stockholder until such stockholder has surrendered such
stockholder's outstanding certificate(s), together with the properly completed
and executed letter of transmittal, to the exchange agent. Any Old Shares
submitted for transfer, whether pursuant to a sale, other disposition or
otherwise, will automatically be exchanged for New Shares. STOCKHOLDERS SHOULD
NOT DESTROY ANY STOCK CERTIFICATES AND SHOULD NOT SUBMIT ANY CERTIFICATES UNTIL
REQUESTED TO DO SO.
NO DISSENTERS' OR APPRAISAL RIGHTS
There is no provision in the Nevada Revised Statutes or in our Articles
of Incorporation, as amended to date, which provides our stockholders with
dissenters' rights or appraisal rights to demand payment in cash for their
shares of common stock in connection with the implementation of the proposal to
amend our Articles of Incorporation to increase our authorized capital stock or
to effectuate the Stock Split.
CONSENT REQUIRED
Pursuant to Sections 78.207 and 78.390 of the Nevada Revised Statutes,
we may amend our Articles of Incorporation and increase our authorized capital
upon the approval by the holders of a majority of the voting power of our common
stock. As of the Record Date, there were 673,608,154 shares of our common stock
issued and outstanding. If we receive approval from the holders of a majority of
our outstanding shares, that will constitute the approval of holders of
sufficient shares to adopt the amendment to our Articles of Incorporation to
increase our authorized capital and effectuate the stock split.
-11-
INFORMATION ABOUT CIRTRAN CORPORATION
The following sets forth the names, ages and positions of our directors
and officers and the officers of our operating subsidiaries, CirTran Corporation
(Utah) and CirTran Asia, along with their dates of service in such capacities.
Name Age Positions
Iehab J. Hawatmeh 39 President, Chief Executive Officer, Chief
Financial Officer, Secretary and Director
of CirTran Corporation; President of
CirTran Corporation
(Utah).
Served since July 2000.
Trevor Saliba 32 Director since June 2001. Senior
Vice-President, Sales and Marketing.
Served since January 2002.
Shaher Hawatmeh 41 Chief Operating Officer
Served since June 2004
Charles Ho 51 President, CirTran-Asia
Served since June 2004
Richard T. Ferrone 58 Chief Financial Officer
Served since May 2006
Iehab J. Hawatmeh, MBA
Chairman, President & CEO
Mr. Iehab Hawatmeh founded CirTran Corporation in 1993 and has been its
Chairman, President and CEO since its inception. Mr. Hawatmeh oversees all daily
operation including financial, technical, operational and sales functions for
the Company. Under Mr. Hawatmeh's direction, the Company has seen its annual
sales exceed $20 million, its employment exceed 360 and completed two strategic
acquisitions. Prior to forming the Company, Mr. Hawatmeh was the Processing
Engineering Manager for Tandy Corporation overseeing the company's entire
contract manufacturing printed circuit board assembly division. In addition, Mr.
Hawatmeh was responsible for developing and implementing Tandy's facility
Quality Control and Processing Plan model which is used by CirTran today. Mr.
Hawatmeh received his Master's of Business Administration from University of
Phoenix and his Bachelor's of Science in Electrical and Computer Engineering
from Brigham Young University. Iehab and Shaher Hawatmeh are brothers.
Trevor M. Saliba, MS
Senior Vice President,
Worldwide Business Development
Mr. Saliba is responsible for sales and marketing activities worldwide and is
responsible for overseeing all worldwide business development strategies for the
Company. Mr. Saliba was elected to the Board of Directors in 2001. From 1997 -
2001 he was President and CEO of Saliba Corp., a privately held contracting firm
he founded. From 1995-1997 he was an Associate with Morgan Stanley. From 1992 -
1995 he was Vice President of Sales and Marketing for SNJ Industries. Mr. Saliba
holds a Bachelors Degree in Business Administration and a Masters Degree in
Finance from La Salle University and has completed an Advanced Graduate Program
in Engineering and Management at the University of California, Berkeley.
-12-
In June 2002 Mr. Saliba filed for personal bankruptcy in the U.S. Bankruptcy
Court in Los Angeles, California, which has not yet been discharged. The
bankruptcy was unrelated to Mr. Saliba's involvement in CirTran.
Shaher Hawatmeh
Chief Operating Officer
Mr. Shaher Hawatmeh joined the Company in 1993 as its Controller shortly after
its founding. Today, Mr. Hawatmeh directly oversees all daily manufacturing
production, customer service, budgeting and forecasting for the Company.
Following the companies acquisition of Pro Cable Manufacturing in 1996, Mr.
Hawatmeh directly managed the entire Company, supervising all operations for
approximately two years and successfully oversaw the integration of this new
division into the Company. Prior to joining CirTran, Mr. Hawatmeh worked for the
Utah State Tax Commission. Mr. Hawatmeh earned his Master's of Business
Administration with an emphasis in Finance from the University of Phoenix and
his Bachelor's of Science in Business Administration and a Minor in Accounting.
Iehab and Shaher Hawatmeh are brothers.
Charles Ho
President, CirTran-Asia
Mr. Ho, who became the President of our CirTran-Asia division on June 15, 2004,
served for six years as the chairman of Meicer Semiconductor Co., Ltd., one of
the leading semiconductor manufacturers located in China, and was a co-founder
of two of the leading design and manufacturing firms of DVD and CD players: Lead
Data Co., Ltd., and Media Group. Mr. Ho has served as CEO for Uking System Inc.
since 1986 and is still holds that position. Mr. Ho has a Master of Business
Administration Degree from the University of South Australia and Bachelor of
Science degree in Industrial Design from National Taipei University of
Technology.
Richard T. Ferrone
Chief Financial Officer
Prior to joining the Company, Mr. Ferrone had headed his own accounting firm,
Ferrone & Associates, which he established in Salt Lake City in 1994.
Previously, he was vice president and CFO for then-publicly-held GCI Industries,
Inc./Golf Card International for seven years, and served as CFO of Huntsman,
Christensen Real Estate & Development Co. Mr. Ferrone had also served as vice
president and chief financial officer for BSD Medical Corporation after he
started his career with a regional CPA firm in Salt Lake City. Mr. Ferrone has a
B.S. in Accounting from the University of Utah, where he also studied for a
Master of Professional Accountancy with a tax emphasis.
At this time, the Company does not have an audit committee. The Company's Board
of Directors acts as the Company's audit committee. Similarly, the Company's
Board of Directors has determined that the Company does not have an audit
committee financial expert as defined under Securities and Exchange Commission
rules.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
During June 2006 the president of the Company loaned the Company a net
amount of $110,837 which was recorded as a note payable to the lender.
During December 2005 the president of the Company loaned the Company
$95,806 which was recorded as a note payable to the lender. The proceeds of this
loan were used to fund on going operations of the Company. In January 2006, the
Company made a payment to the lender which repaid the entire balance ($95,806)
of the loan.
As of December 31, 2001, Iehab Hawatmeh had loaned us a total of
$1,390,125. The loans were demand loans, bore interest at 10% per annum and were
unsecured. Effective January 14, 2002, we entered into four substantially
identical agreements with existing shareholders pursuant to which we issued an
-13-
aggregate of 43,321,186 shares of restricted common stock at a price of $0.075
per share for $500,000 in cash and the cancellation of $2,749,090 principal
amount of our debt. Two of these agreements were with the Saliba Private Annuity
Trust, one of our principal shareholders, and a related entity, the Saliba
Living Trust. The Saliba trusts are also principals of Abacas Ventures, Inc.,
which entity purchased our line of credit in May 2000. Pursuant to the Saliba
agreements, the trusts were issued a total of 26,654,520 shares of common stock
in exchange for $500,000 cash and the cancellation of $1,499,090 of debt. We
used the $500,000 cash from the sale of the shares for working capital. As a
result of this transaction, the percentage of our common stock owned by the
Saliba Private Annuity Trust and the Saliba Living Trust increased from
approximately 6.73% to approximately 17.76%. Mr. Trevor Saliba, one of our
directors and officers, is a passive beneficiary of the Saliba Private Annuity
Trust. Pursuant to the other two agreements made in January 2002, we issued an
aggregate of 16,666,666 shares of restricted common stock at a price of $0.075
per share in exchange for the cancellation of $1,250,000 of notes payable by two
shareholders, Mr. Iehab Hawatmeh (our president, a director and our principal
shareholder) and Mr. Rajai Hawatmeh. Of these shares, 15,333,333 were issued to
Iehab Hawatmeh in exchange for the cancellation of $1,150,000 in debt. As a
result of this transaction, the percentage of our common stock owned by Mr.
Hawatmeh increased from 19.9% to approximately 22.18%.
In February 2000, prior to its acquisition of Vermillion Ventures,
Inc., a public company, Circuit Technology, Inc., while still a private entity,
redeemed 680,145 shares (as presently constituted) of common stock held by Raed
Hawatmeh, who was a director of Circuit Technology, Inc. at that time, in
exchange for $80,000 of expenses paid on behalf of the director. No other stated
or unstated rights, privileges, or agreements existed in conjunction with this
redemption. This transaction was consistent with other transactions where shares
were offered for cash.
In 1999, Circuit entered into an agreement with Cogent Capital Corp.,
or "Cogent," a financial consulting firm, whereby Cogent agreed to assist and
provide consulting services to Circuit in connection with a possible merger or
acquisition. Pursuant to the terms of this agreement, we issued 800,000
(pre-forward split) restricted shares (12,000,000 post-forward split shares) of
our common stock to Cogent in July 2000 in connection with our acquisition of
the assets and certain liabilities of Circuit. The principal of Cogent was
appointed a director of Circuit after entering into the financial consulting
agreement and resigned as a director prior to the acquisition of Circuit by
Vermillion Ventures, Inc. on July 1, 2000.
Also, as of December 31, 2004 the company owed I&R Properties, LLC, the
previous owner of our principal office and manufacturing facility for unpaid
accrued rent and accrued interest. The Company settled with owed I&R Properties,
LLC., on accrued rent and interest of $400,000 by issuing 10,000,000 shares of
unregistered common stock in March 2005.
Management believed at the time of each of these transactions and
continues to believe that each of these transactions were as fair to the Company
as could have been made with unaffiliated third parties.
Abacas Ventures
An explanation of the relationship between CirTran and Abacas Ventures,
Inc., is as follows:
Two trusts, the Saliba Living Trust and the Saliba Private Annuity
Trust (collectively, the "Saliba Trusts"), were investors in Circuit Technology,
a Utah corporation and predecessor entity of the Company. The trustees of the
trusts are Tom and Betty Saliba, and Tom Saliba, respectively. (Tom Saliba is
the nephew of the grandfather of Trevor Saliba, one of the directors of
CirTran.) In July 2000, CirTran Corporation merged with Circuit Technology.
Through that merger, the Saliba Trusts became shareholders of CirTran. The
Saliba Trusts are also two of the shareholders of an entity named Abacas
Ventures, Inc. ("Abacas"). At the time of the merger, CirTran was in default on
several of its obligations, including an obligation to Imperial Bank. The Saliba
Trusts, through Abacas, purchased the bank's claim against CirTran to protect
their investment in CirTran. Since that time, Abacas has continued to settle
debts of CirTran to improve Abacas's position and to take advantage of certain
discounts that creditors of CirTran offered to settle their claims. On two
occasions, the Abacas shareholders have agreed to convert outstanding debt owed
by CirTran to Abacas into shares of CirTran common stock (discussed below).
-14-
Abacas continues to work with the company to settle claims by creditors against
CirTran, and, on occasion, to provide funding. There can be no assurance that
Abacus will agree to convert its existing debt, or any debt it acquires in the
future, into shares of CirTran, or that conversions will occur at a price and on
terms that are favorable to CirTran. If Abacus and CirTran cannot agree on
acceptable conversion terms, Abacus may demand payment of some or all of the
debt. If CirTran does not have sufficient cash or credit facilities to pay the
amount then due and owing by CirTran to Abacus, Abacus may exercise its rights
as a senior secured lender and commence foreclosure or other proceedings against
the assets of CirTran. Such actions by Abacus could have a material adverse
effect upon CirTran and its ability to continue in business.
In January, 2002, the Company entered into an agreement with Abacas
under which the Company issued an aggregate of 19,987,853 shares of common stock
to four of Abacas's shareholders in exchange for cancellation by Abacas of an
aggregate amount of $1,499,090 in senior debt owed to the creditors by the
Company. The shares were issued with an exchange price of $0.075 per share, for
the aggregate amount of $1,500,000.
In December, 2002, the Company entered into an agreement with Abacas
under which the Company issued an aggregate of 30,000,000 shares of common stock
to four of Abacas's shareholders in exchange for cancellation by Abacas of an
aggregate amount of $1,500,000 in senior debt owed to the creditors by the
Company. The shares were issued with an exchange price of $0.05 per share, for
the aggregate amount of $1,500,000.
During 2002, the Company entered into a verbal bridge loan agreement
with Abacas. This agreement allows the Company to request funds from Abacas to
finance the build-up of inventory relating to specific sales. The loan bears
interest at 24% and is payable on demand. There are no required monthly
payments. During the years ended December 31, 2004 and 2003, the Company was
advanced $3,128,281 and $350,000, respectively, and made cash payments of
$3,025,149 and $875,000, respectively.
During the year ended December 31, 2004, Abacas completed negotiations
with several vendors of the Company, whereby Abacas purchased various past due
amounts for goods and services provided by vendors, as well as notes payable
(see Note 6). The total of these obligations was $1,263,713. The Company has
recorded this transaction as a $1,263,713 non-cash increase to the note payable
owed to Abacas, pursuant to the terms of the Abacas agreement.
The total principal amount owed to Abacas between the note payable and
the bridge loan was $1,530,587 and $163,742 as of December 31, 2004 and 2003,
respectively. The total accrued interest owed to Abacas between the note payable
and the bridge loan was $430,828 and $230,484 as of December 31, 2004 and 2003,
respectively, and is included in accrued liabilities.
In March 2005, the shareholders of Abacas agreed to cancel $2,050,000
of principal and accrued interest in return for the Company's issuing 51,250,000
shares of our restricted common stock to certain shareholders of Abacas. No
registration rights were granted.
As of January 29, 2007, no further loans had been made to the Company
from Abacas.
Compliance With Section 16(a) of the Exchange Act
Section 16(a) of the Securities Exchange Act of 1934 requires our
officers and directors, and persons who beneficially own more than 10% of a
registered class of our equity securities, to file reports of ownership and
changes in ownership with the Securities and Exchange Commission. Officers,
directors and greater than 10% shareholders are required by regulation of the
Securities and Exchange Commission to furnish us with copies of all Section
16(a) forms which they file. Based solely on its review of the copies of such
forms furnished to us during the fiscal year ended December 31, 2005, we are
aware of the following untimely filings:
Iehab Hawatmeh, Raed Hawatmeh, Trevor Saliba and Shaher Hawatmeh all
filed untimely Forms 5.
-15-
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth the number and percentage of the
655,716,326 outstanding shares of our common stock which, according to the
information supplied to us, were beneficially owned, as of January 1, 2007, by
(i) each person who is currently a director, (ii) each executive officer, (iii)
all current directors and executive officers as a group and (iv) each person
who, to our knowledge, is the beneficial owner of more than 5% of our
outstanding common stock.
Except as otherwise indicated, the persons named in the table have sole
voting and dispositive power with respect to all shares beneficially owned,
subject to community property laws where applicable. Beneficial ownership is
determined according to the rules of the Securities and Exchange Commission, and
generally means that person has beneficial ownership of a security if he or she
possesses sole or shared voting or investment power over that security. Each
director, officer, or 5% or more shareholder, as the case may be, has furnished
us information with respect to beneficial ownership. Except as otherwise
indicated, we believe that the beneficial owners of the common stock listed
below, based on the information each of them has given to us, have sole
investment and voting power with respect to their shares, except where community
property laws may apply.
--------------------------------------------------------------------------------
Percent
Name and Address Relationship Common Shares of Class
--------------------------------------------------------------------------------
Saliba Private Annuity Trust (1) 5% 75,698,990 11.54%
115 S. Valley Street Shareholder
Burbank, CA 91505
--------------------------------------------------------------------------------
Iehab J. Hawatmeh Director, 60,000,000 9.15%
4125 South 6000 West Officer
West Valley City, Utah 84128 & 5%
Shareholder
--------------------------------------------------------------------------------
Raed Hawatmeh (3) Former 24,000,000 3.63%
10989 Bluffside Drive Director
Studio City, CA 91604
--------------------------------------------------------------------------------
Trevor Saliba (2) Director 9,000,000 1.37%
13848 Valleyheart Drive
Sherman Oaks, CA 91423
--------------------------------------------------------------------------------
Charles Ho Officer of 0 0.00%
4125 South 6000 West Subsidiary
West Valley City, Utah 84128 of Company
--------------------------------------------------------------------------------
Shaher Hawatmeh Chief Operating 1,000,000 0.15%
4125 South 6000 West Officer
West Valley City, Utah 84128
--------------------------------------------------------------------------------
Richard T. Ferrone Chief Financial 0 0.00%
4125 South 6000 West Officer
West Valley City, Utah 84128
--------------------------------------------------------------------------------
All Officers and Directors 70,000,000 10.68%
as a Group (4 persons)
--------------------------------------------------------------------------------
___________________
-16-
(1) Includes 13,189,620 shares held by the Saliba Living Trust. Thomas L.
Saliba and Betty R. Saliba are the trustees of The Saliba Living Trust and
Thomas L. Saliba is the sole trustee of The Saliba Private Annuity Trust. These
persons control the voting and investment decisions of the shares held by the
respective trusts. Mr. Thomas L. Saliba is a nephew of the grandfather of Mr.
Trevor Saliba, one of our directors and officers. Mr. Trevor Saliba is one of
five passive beneficiaries of Saliba Private Annuity Trust and has no control
over its operations or management. Mr. Saliba disclaims beneficial control over
the shares indicated.
(2) Includes options to purchase up to 1,000,000 shares each that can
exercised anytime at exercise prices of $0.027 per share.
(3) Includes options to purchase up to 6,250,000 shares that can be anytime
at exercise prices of $0.02 - $0.03 per share. Raed Hawatmeh resigned from the
Company's Board of Directors on May 10, 2006.
BOARD OF DIRECTORS MEETINGS, COMMITTEES AND DIRECTOR COMPENSATION
PLEASE NOTE: In 2006, the SEC revised its disclosure requirements
relating to compensation of directors and named executive officers. Small
Business Issuers are required to provide the information under the new
disclosure format for 2006, but are not required to conform the disclosure for
prior years to the new format. The following information consists of the new
format disclosure for 2006, and for purposes of providing information to our
shareholders, the prior format disclosure for prior years.
Compensation Discussion and Analysis
The following is a discussion of the Company's program for compensation
of its named executive officers and directors. As of the date of this Report,
the Company did not have a compensation committee, and as such, the Company's
Board of Directors were responsible for determining the Company's compensation
program.
Compensation Program Objectives
The Company's compensation program is designed to encompass several
factors in determining the compensation of the Company's named executive
officers. The following are the main objectives of the compensation program for
the Company's named executive officers:
- Retain qualified officers.
- Provide overall corporate direction for the officers and also to
provide direction that is specific to officer's respective areas
of authority. The level of compensation amongst the officer group,
in relation to one another, is also considered in order to
maintain a high level of satisfaction within the leadership group.
We consider the relationship that the officers maintain to be one
of the most important elements of the leadership group.
- Provide a performance incentive for the officers.
The Company's compensation program is designed to reward the officers
in the following areas:
- achievement of specific goals;
- professional education and development;
- creativity in the form of innovative ideas and analysis for new
programs and projects;
- new program implementation;
- attainment of company goals, budgets, and objectives;
- results oriented determination and organization;
- positive and supportive direction for company personnel; and
- community involvement.
As of the date of this Report, there were four principal elements of
named executive officer compensation. The Board of Directors determines the
portion of compensation allocated to each element for each individual named
-17-
executive officer. The discussions of compensation practices and policies are of
historical practices and policies. Our Board of Directors is expected to
continue these policies and practices, but will reevaluate the practices and
policies as it considers advisable.
The elements of the compensation program include:
- Base salary;
- Performance bonus and commissions;
- Stock options and stock awards
- Employee benefits in the form of:
- health and dental insurance;
- life insurance;
- paid parking and auto reimbursement; and
- Other de minimis benefits.
Base salary
Base salary is intended to provide competitive compensation for job
performance and to attract and retain qualified named executive officers. The
base salary level is determined by considering several factors inherent in the
market place such as: the size of the company; the prevailing salary levels for
the particular office or position; prevailing salary levels in a given
geographic locale; and the qualifications and experience of the named executive
officer.
Performance bonus and commissions
Bonuses are in large part based on company performance. An EBITDA
formula is the sole determining factor used to calculate the performance bonus
for the Chief Executive Officer and Chief Operating Officer.
The Marketing Officer receives a performance bonus based on the EBITDA
formula and also a commission based on a percentage of sales revenue.
The Chief Financial Officer receives a performance bonus based on
performance, as determined by the Board of Directors, at minimum amount that has
been established as part of an employment contract.
Policy decisions to waive or modify performance goals have not been a
significant factor to date in that there have not been contractual changes made
other than the normal renewal or updating of contracts as would be expected as
part of an annual review.
Stock options and stock awards
Stock ownership is provided to enable named executive officers and
directors to participate in the success of the Company. The direct or potential
ownership of stock will also provide the incentive to expand the involvement of
the named executive officer to include, and therefore be mindful of, the
perspective of stockholders of the Company.
Employee benefits
Several of the employee benefits for the named executive officers are
selected to provide security for the named executive officers. Most notably,
insurance coverage for health, life, and liability are intended to provide a
level of protection to that will enable the named executive officers to function
without having the distraction of having to manage undue risk. The health
insurance also provides access to preventative medical care which will help the
named executive officers function at a high energy level, to manage job related
stress, and contribute to the overall well being of the named executive
officers, all of which contribute to an enhanced job performance.
-18-
Other de minimis benefits
Other de minimis employee benefits such as cell phones, parking, and
auto usage reimbursements are directly related to job functions but contain a
personal use element which is considered to be a goodwill gesture that
contributes to enhanced job performance.
As discussed above, the Board of Directors determines the portion of
compensation allocated to each element for each individual named executive
officer. As a general rule, salary is competitively based while giving
consideration to employee retention, qualifications, performance, and general
market conditions. Typically, stock options are based on the current market
value of the option and how that will contribute to the overall compensation of
the named executive officer. Consideration is also given to the fact that the
option has the potential for an appreciated future value. As such, the future
value may be the most significant factor of the option, but it is also more
difficult to quantify as a benefit to the named executive officer.
Accordingly, in determining the compensation program for the Company,
as well as setting the compensation for each named executive officer, the Board
of Directors attempts to attract the interest of the named executive officer
within in the constraints of a compensation package that is fair and equitable
to all parties involved.
EXECUTIVE COMPENSATION
SUMMARY COMPENSATION TABLE
------------------------------------------------------------------------------------------------------------------------------------
Change in
Pension Value
and
Bonus Nonqualified
Name and Or Non-Equity Deferred
Principal Commission Stock Option Incentive Plan Compensation All Other
Position Year Salary (C) Awards Grants Compensation Earnings Compensation Total
$ $ $
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)
------------------------------------------------------------------------------------------------------------------------------------
Iehab Hawatmeh,
President and
Chief Executive
Officer 2006 225,000 57,807 -0- -0- -0- -0- -0- 282,807
------------------------------------------------------------------------------------------------------------------------------------
Richard Ferrone
Chief Financial
Officer 2006 73,845 21,000 -0- -0- -0- -0- -0- 94,845
------------------------------------------------------------------------------------------------------------------------------------
Trevor Saliba,
Chief Marketing
Officer 2006 120,000 18,755 -0- -0- -0- -0- -0- 138,755
------------------------------------------------------------------------------------------------------------------------------------
Shaher Hawatmeh,
Chief Operating
Officer 2006 150,000 7,790 -0- -0- -0- -0- -0- 157,790
------------------------------------------------------------------------------------------------------------------------------------
Charles Ho
President
CirTran Asia 2006 -0- 407,397(C) -0- -0- -0- -0- -0- 407,397
------------------------------------------------------------------------------------------------------------------------------------
(1) For each of the individuals listed in the table above, "All Other
Compensation" would include perquisites including cellular phones, automobile
reimbursement, parking reimbursement, life insurance, and health and dental
insurance. However, the aggregate value of all such perquisite compensation is
-19-
less than $10,000 for each of the individuals named in the table above.
Additionally, the Company believes that each of the elements of perquisite
compensation listed are integrally and directly related to the performance of
the executive duties of the individuals listed above, although certain of the
elements (including cellular phone use and automobile reimbursement) may have a
personal benefit component as well.
Narrative Disclosure to Summary Compensation Table.
---------------------------------------------------
Employment Agreements
On July 1, 2004, CirTran Corporation entered into an employment
agreement with Iehab Hawatmeh, dated as of June 26, 2004. The agreement, which
is for a term of five years and renews automatically on a year-to year basis,
provides for a base salary of $225,000, plus a bonus of 5% of our earnings
before interest, taxes, depreciation, and amortization, payable quarterly, as
well as any other bonus our board of directors may approve. Under the Agreement,
Mr. Hawatmeh agreed to serve as our Chief Executive Officer and President and to
perform such other duties as delegated by our board of directors. The agreement
provides for benefits including health insurance coverage, cell phone, car
allowance, life insurance, and D&O insurance. Under the Agreement, Mr.
Hawatmeh's employment may be terminated for cause, or upon his death or
disability. In the event that Mr. Hawatmeh is terminated without cause, we are
obligated to pay him, as a severance payment, an amount equal to five full years
of his then-current annual base compensation, half upon such termination and
half one year later, together with a continuation of insurance benefits for a
period of five years.
In May 2006, we entered into a three-year employment contract with
Richard Ferrone to serve as the Chief Financial Officer of the Company to
perform those duties delegated by the Board of Directors and the President of
the Company and all other duties consistent with such description. The term of
his employment started on May 15, 2006, and will continue for three years
thereafter, unless sooner terminated by either party as provided in the
agreement. Thereafter, the agreement will be automatically renewed on a
year-to-year basis after the expiration of the initial or any subsequent term of
the Agreement unless terminated by either party as provided in the agreement.
Mr. Ferrone will receive, commencing on May 15, 2006, a base salary of
$120,000.00 per year. The base salary shall be reviewed by the Board annually
and may be increased as determined by the Board. The Board's determination of
salary will be based primarily on Mr. Ferrone's ability to meet, and to cause
the Company to meet, annually established goals. He is also entitled to a bonus
of $40,000 per year, payable in quarterly increments. In addition, he may be
granted options to purchase shares of the Company's common stock as determined
from time to time by the Board or the Committee established pursuant to the
Company's Stock Option Plan.
On July 1, 2004, CirTran Corporation entered into an employment
agreement with Trevor Saliba, dated as of June 26, 2004. The agreement, which is
for a term of three years and renews automatically on a year-to year basis,
provides for a base salary of $120,000, plus a bonus of 1% of our gross sales
generated directly by Mr. Saliba, a bonus of 5% of all gross investments made
into CirTran which are directly generated and arranged by Mr. Saliba, a bonus of
1% of the net purchase price of any acquisitions completed by us which are
directly generated and arranged by Mr. Saliba (payable in CirTran common stock),
as well as any other bonus our board of directors may approve. Under the
Agreement, Mr. Saliba agreed to serve as our Executive Vice President of Sales
and Marketing, and to perform such other duties as delegated by our board of
directors. The agreement provides for benefits including health insurance
coverage, cell phone, car allowance, life insurance, and D&O insurance. Under
the Agreement, Mr. Saliba's employment may be terminated for cause, or upon his
death or disability. In the event that Mr. Saliba is terminated without cause,
we are obligated to pay him, as a severance payment, an amount equal to one
years' salary. If the Agreement expires of its terms or is terminated for any
reason, Mr. Saliba may not compete with us for a period of one year from the
date of termination of the agreement. Mr. Saliba also agreed not to solicit our
employees or customers, or attempt to induce anyone to cease doing business with
us for a period of two years after the termination of the agreement.
On July 1, 2004, we also entered into an employment agreement, dated as
of June 26, 2004, with Shaher Hawatmeh, the brother of Iehab Hawatmeh. The
agreement, which is for a term of three years and renews automatically on a
-20-
year-to year basis, provides for a base salary of $150,000, plus a bonus of 1%
of our earnings before interest, taxes, depreciation, and amortization, payable
quarterly, as well as any other bonus our board of directors may approve. Under
the Agreement, Mr. Shaher Hawatmeh agreed to serve as our Chief Operating
Officer, and to perform such other duties as delegated by our board of
directors. The agreement provides for benefits including health insurance
coverage, cell phone, life insurance, and D&O insurance. Under the Agreement,
Mr. Shaher Hawatmeh's employment may be terminated for cause, or upon his death
or disability. In the event that Mr. Shaher Hawatmeh is terminated without
cause, we are obligated to pay him, as a severance payment, an amount equal to
one years' salary. If the Agreement expires of its terms or is terminated for
any reason, Mr. Shaher Hawatmeh may not compete with us for a period of one year
from the date of termination of the agreement. Mr. Shaher Hawatmeh also agreed
not to solicit our employees or customers, or attempt to induce anyone to cease
doing business with us for a period of two years after the termination of the
agreement.
On June 15, 2004, our subsidiary, CirTran-Asia, entered into an
employment agreement with Charles Ho. The agreement, which is for a term of
three years and renews automatically on a year-to year basis, provides that for
each additional product that Mr. Ho procures pursuant to the agreement between
CirTran-Asia and Michael Casey Enterprises, LTD., Mr. Ho shall be entitled to
receive such compensation as provided for in that agreement in the form of
options to purchase shares of CirTran common stock. Under the Agreement,
CirTran-Asia will not provide benefits to Mr. Ho, and his employment may be
terminated for cause, or upon his death or disability. If the Agreement expires
of its terms or is terminated for any reason, Mr. Ho may not compete with us for
a period of one year from the date of termination of the agreement. Mr. Ho also
agreed not to solicit our employees or customers, or attempt to induce anyone to
cease doing business with us for a period of two years after the termination of
the agreement.
OUTSTANDING EQUITY AWARDS AT FISCAL 2006 YEAR-END
------------------------------------------------------------------------------------------------------------------------------------
Option Awards Stock Awards
--------------- ---------------------------------------------------------------- --------------------------------------------------
Name Number of Number of Equity Option Option Number of Market Value Equity Equity
Securities Securities Incentive Plan Exercise Expiration Shares or of Shares or Incentive Incentive
Underlying Underlying Awards: Number Price ($) Date Units of Units of Plan Awards: Plan Awards:
Unexercised Unexercised of Securities Stock That Stock That Number of Market or
Options (#) Options Underlying Have Not Have Not Unearned Payout Value
Exercisable (#) Unexercised Vested (#) Vested ($) Shares, of Unearned
Unexercisable Unearned Units, or Shares,
Options Other Rights Units, or
(#) That Have Other Rights
Not Vested That Have
(#) Not Vested
($)
(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
Iehab Hawatmeh, -0- -0- -0- N/A N/A -0- -0- -0- -0-
CEO
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
Richard -0- -0- -0- N/A N/A -0- -0- -0- -0-
Ferrone, CFO
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
Trevor Saliba, -0- -0- -0- N/A N/A -0- -0- -0- -0-
CMO
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
Shaher -0- -0- -0- N/A N/A -0- -0- -0- -0-
Hawatmeh, COO
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
Charles Ho, -0- -0- -0- N/A N/A -0- -0- -0- -0-
President
CirTran Asia
--------------- ----------- ------------- -------------- --------- ---------- --------- ------------ ----------- ------------
-21-
(1) Two Officers of the company exercised shares of stock that had
been awarded from to them from the 2004 Stock Option Program. Trevor Saliba,
Chief Marketing Officer, exercised a total of 3,000,000 shares, and Shaher
Hawatmeh, Chief Operating Officer, exercised a total of 2,000,000 shares during
2006.
DIRECTOR COMPENSATION
For Fiscal Year Ended 2006
--------------- ---------------- -------------- --------------- ---------------- ----------------- -------------- -----------------
Name Fees Earned or Stock Awards Option Awards Non-Equity Change in All Other Total
Paid in Cash ($) ($) Incentive Plan Pension Value Compensation ($)
($) Compensation and Nonqualified ($)
($) Deferred
Compensation
Earnings
($)
(a) (b) (c) (d) (e) (f) (g) (h)
--------------- ---------------- -------------- --------------- ---------------- ----------------- -------------- -----------------
Iehab Hawatmeh -0- -0- -0- -0- -0- -0- -0-
(Note 1)
--------------- ---------------- -------------- --------------- ---------------- ----------------- -------------- -----------------
Trevor Saliba -0- -0- -0- -0- -0- -0- -0-
(Note 1)
--------------- ---------------- -------------- --------------- ---------------- ----------------- -------------- -----------------
Raed Hawatmeh -0- -0- -0- -0- -0- -0- -0-
(Note 2)
--------------- ---------------- -------------- --------------- ---------------- ----------------- -------------- -----------------
(1) Iehab Hawatmeh and Trevor Saliba also served as executive officers of the
Company during the fiscal year ended December 31, 2006. They received
compensation for their services as executive officers, set forth above in the
Summary Compensation Table. They did not receive any additional compensation for
their services as directors of the Company.
(2) Mr. Raed Hawatmeh resigned as a director of the Company on May 10, 2006.
During his term of service in 2006, he did not receive any compensation for his
services as director of the Company.
The Company does not have standing audit, nominating, or compensation
committees. Those functions are performed by the board of directors.
Please note: On February 1, 2007, Fadi Nora was appointed to the
Company's Board of Directors.
PRIOR YEARS EXECUTIVE COMPENSATION INFORMATION
The following table sets forth certain information regarding the annual
and long-term compensation for services to us in all capacities for the prior
fiscal years ended December 31, 2005, 2004, 2003, and 2002 of those persons who
were either (i) the chief executive officer during the last completed fiscal
year or (ii) one of the other four most highly compensated executive officers as
of the end of the last completed fiscal year. The individuals named below
received no other compensation of any type, other than as set out below, during
the fiscal years indicated.
-22-
--------------------------------------------------------------------------------------------------------------
Annual Compensation Long-Term Compensation Awards
------------------- -----------------------------
Restricted
Bonus/ Stock Stock
Name and Salary Commission Awards Options All Other
Principal Position Year ($) ($) ($) (#) Compensation
--------------------------------------------------------------------------------------------------------------
Iehab J. Hawatmeh 2005 225,000 114,219 6,000,000 -
President, Secretary, 2004 200,000 - - 3,500,000 -
Treasurer and Director 2003 175,000 - - 6,500,000 -
2002 175,000 - - 1,850,000
--------------------------------------------------------------------------------------------------------------
Trevor M. Saliba 2005 120,000 31,895 5,000,000 -
Sr. Vice President and 2004 108,000 - - 4,250,000 -
Director of CirTran 2003 127,000 - - 3,000,000 -
Corporation 2002 118,000 - - 500,000
--------------------------------------------------------------------------------------------------------------
Raed S. Hawatmeh 2005 - - - 4,000,000 -
Director of CirTran 2004 - - - 2,500,000 -
Corporation 2003 - - - 3,000,000 -
2002 - - - 500,000 -
--------------------------------------------------------------------------------------------------------------
Shaher Hawatmeh 2005 150,000 30,000 - 2,000,000 -
Chief Operating Officer 2004 140,000 - - 4,700,000 -
2003 120,000 - - 8,400,000 -
2002 120,000 - - 2,500,000 -
--------------------------------------------------------------------------------------------------------------
Charles Ho 2005 460,126 500,000 -
President of CirTran Asia 2004 - 157,389 - - -
2003 - - - - -
2002 - - - - -
--------------------------------------------------------------------------------------------------------------
Option/SAR Grants in the Year Ended December 31, 2005
--------------- ------------ --------------- ---------------- ---------------
Number of
Securities % of Total
Underlying Options Granted
Options/SARs to Employees in Exercise or Base
Name Granted (#) Fiscal Year Price ($/Sh) Expiration Date
--------------- ------------ --------------- ---------------- ---------------
Iehab Hawatmeh 6,000,000 30.00% $0.022 - $0.027 Jan - Dec 2010
--------------- ------------ --------------- ---------------- ---------------
Trevor Saliba 5,000,000 25.00% $0.022 - $0.027 Jan - Dec 2010
--------------- ------------ --------------- ---------------- ---------------
Raed Hawatmeh 4,000,000 20.00% $0.022 - $0.027 Jan - Dec 2010
--------------- ------------ --------------- ---------------- ---------------
Shaher Hawatmeh 2,000,000 10.00% $0.023 - $0.027 Jan - Dec 2010
--------------- ------------ --------------- ---------------- ---------------
Charles Ho 500,000 2.00% $0.06 Jan 2006
--------------- ------------ --------------- ---------------- ---------------
-23-
Option/SAR Grants in the Year Ended December 31, 2004
--------------- ------------ --------------- ---------------- ---------------
Number of
Securities % of Total
Underlying Options Granted
Options/SARs to Employees in Exercise or Base
Name Granted (#) Fiscal Year Price ($/Sh) Expiration Date
--------------- ------------ --------------- ---------------- ---------------
Iehab Hawatmeh 3,500,000 14.58% $0.015 - $0.03 Jan - Dec 2009
--------------- ------------ --------------- ---------------- ---------------
Trevor Saliba 4,250,000 17.71% $0.015 - $0.03 Jan - Dec 2009
--------------- ------------ --------------- ---------------- ---------------
Raed Hawatmeh 3,500,000 14.58% $0.015 - $0.03 Jan - Dec 2009
--------------- ------------ --------------- ---------------- ---------------
Shaher Hawatmeh 4,700,000 19.58% $0.01 - $0.03 Jan - Dec 2009
--------------- ------------ --------------- ---------------- ---------------
Aggregated Option/SAR Exercises in the Year Ended December 31, 2005 and December
31, 2004 Option/SAR Values
--------------- --------------- ------------ --------------- ----------------
Number of
Securities Value of
Underlying Unexercised
Unexercised In-the-Money
Options/SARs Options/SARs at
at FY End (#) FY-End ($)
Shares Acquired Value Exercisable/ Exercisable/
Name on Exercise (#) Realized ($) Unexercisable Unexercisable
--------------- --------------- ------------ --------------- ----------------
Iehab Hawatmeh 8,000,000 $198,000 - $ -
--------------- --------------- ------------ --------------- ----------------
Trevor Saliba 4,000,000 $100,000 3,000,000/0 $ 71,000/0
--------------- --------------- ------------ --------------- ----------------
Raed Hawatmeh 3,000,000 $ 73,000 5,250,000/0 $123,500/0
--------------- --------------- ------------ --------------- ----------------
Shaher Hawatmeh 1,000,000 $ 23,000 2,000,000/0 -
--------------- --------------- ------------ --------------- ----------------
Charles Ho - - 500,000/0 -
--------------- --------------- ------------ --------------- ----------------
Aggregated Option/SAR Exercises in the Year Ended December 31, 2005 and December
31, 2004 Option/SAR Values
--------------- --------------- ------------ --------------- ----------------
Number of
Securities Value of
Underlying Unexercised
Unexercised In-the-Money
Options/SARs Options/SARs at
at FY End (#) FY-End ($)
Shares Acquired Value Exercisable/ Exercisable/
Name on Exercise (#) Realized ($) Unexercisable Unexercisable
--------------- --------------- ------------ --------------- ----------------
Iehab Hawatmeh 1,500,000 $ 33,750 - $ -
--------------- --------------- ------------ --------------- ----------------
Trevor Saliba 2,250,000 $ 56,250 - $ -
--------------- --------------- ------------ --------------- ----------------
Raed Hawatmeh 750,000 $ 11,250 2,250,000/0 $ 52,500/0
--------------- --------------- ------------ --------------- ----------------
Shaher Hawatmeh 3,700,000 $ 56,000 1,000,000/0 $ -
--------------- --------------- ------------ --------------- ----------------
Options issuable in connection with Manufacturing Agreement -- On June
10, 2004, we entered into an exclusive manufacturing agreement with certain
Developers, including Charles Ho, the President of CirTran-Asia. Under the terms
of the agreement, we, through our wholly owned subsidiary CirTran-Asia, have the
exclusive right to manufacture certain products developed by the Developers or
any of their affiliates. In connection with this agreement, we identified seven
products, in connection with which we agreed to issue options to purchase shares
common stock to the Developers upon the sale, shipment and payment for specified
amounts of units of a the identified products, as set forth below. The options
will be exercisable at $0.06 per share, vest on the grant date and expire one
year after issuance. The schedule of units and potential options that will be
issued follows:
-24-
--------------------- ------- ----------- ------------- ------------- -------------
Options
Options for Each Issued
Initial Multiple of Options for Through
Initial Units Units Above Each Multiple January 29,
Product Units Sold(1) Initial Units of Units 2007
--------------------- ------- ----------- ------------- ------------- -------------
Ab King Pro 500,000 500,000 100,000 100,000 1,500,000 (3)
--------------------- ------- ----------- ------------- ------------- -------------
Ab Roller 500,000 500,000 200,000 100,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
Ab Trainer Club Pro 25,000 500,000 15,000 100,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
Instant Abs 100,000 500,000 50,000 100,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
Hot Dog Express (2) 300,000 1,000,000 100,000 200,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
Condiment Caddy 200,000 250,000 100,000 100,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
Denise Austin Pilates 200,000 500,000 100,000 100,000 ________
--------------------- ------- ----------- ------------- ------------- -------------
(1) Except as set forth in Notes (2) and (3), the options set forth in this
table are issuable to Charles Ho, President of our subsidiary CirTran-Asia.
(2) Of the options for initial units sold for this product, Mr. Ho, President
of CirTran-Asia, is entitled to receive 700,000, with the remaining 300,000
going to the other developer. For each multiple of units above the initial
units, Mr. Ho and the other developer are each entitled to receive an additional
100,000 options, for an aggregate of 200,000 options.
(3) Of the options issued in connection with this product, Mr. Ho received
500,000, and two other developers each received 500,000 options. All of these
options expired of their terms in January 2006.
As of January 29, 2007, we had issued a total of 1,500,000 options
pursuant to the agreement relating to the Ab King Pro, but had not received
sufficient orders or shipped sufficient quantities of the other products listed
in the table to trigger the issuance of additional options. Of the 1,500,000
options issued, Mr. Ho received 500,000 options. The 1,500,000 options were
issued with an exercise price of $0.06 per share, and all 1,500,000 options
expired in January 2006 pursuant to their terms.
During 2004, Mr. Ho received approximately $157,400 in commissions in
connection with the manufacturing agreement. During 2005, Mr. Ho received
approximately $460,200 in commissions in connection with the manufacturing
agreement. During 2006, Mr. Ho received approximately $328,000 in commissions in
connection with the manufacturing agreement.
Mr. Ho's commissions are calculated by predetermined percentages from
manufacturing agreements and/or appendixes. Most of the commissions are
calculated using the sales price less freight and cost of sales to the factory,
that amount is then multiplied by the contract percentage, per unit for each
product, after the payment has been received.
-25-
Recent Developments
Entry into Amendment Agreements
On January 12, 2007, CirTran Corporation (the "Company"), entered into
two agreements with Cornell Capital Partners, LP ("Cornell"), both of which
amended prior agreements with Cornell.
The Company entered into an Amendment Number 2 to Amended and Restated
Investor Registration Rights Agreement ("Amendment No. 2") with Cornell, which
amended an Amended and Restated Investor Registration Rights Agreement dated as
of August 23, 2006, as amended October 30, 2006. The purpose of Amendment No. 2
was to extend the filing deadline for a registration statement to be filed by
the Company to register the resale by Cornell of shares of the Company's common
stock issuable to Cornell upon conversion of a convertible debenture in the
aggregate principal amount of $1,500,000 (the "August Debenture") issued to
Cornell in August 2006. The new filing deadline for the registration statement
is June 1, 2007.
The Company also entered into an Amendment Number 4 to Investor
Registration Rights Agreement ("Amendment No. 4") with Cornell, which amended an
Investor Registration Rights Agreement dated as of December 30, 2005, as most
recently amended October 30, 2006. The purpose of Amendment No. 4 was to extend
the filing deadline for a registration statement to be filed by the Company to
register the resale by Cornell of shares of the Company's common stock issuable
to Cornell upon conversion of a convertible debenture in the aggregate principal
amount of $1,500,000 (the "December Debenture") issued to Cornell in December
2005. The new filing deadline for the registration statement is June 1, 2007.
Entry into Exclusive Manufacturing and Supply Agreement
On November 30, 2006, CirTran Corporation (the "Company"), entered into
an Exclusive Manufacturing and Supply Agreement (the "Agreement") with Evolve
Projects, LLC ("Evolve"), an Ohio-based limited liability company.
The term of the Agreement (the "Term") is for five years from
execution, and may be continued on a month-to-month basis thereafter. The
Agreement relates to the manufacturing and production of a new fitness product
(the "Product"). Under the Agreement, Evolve committed to minimum orders of at
least 20,000 units during the first year of the Term, at least 30,000 units
during the second year of the Term, and at least 40,000 units during the third
year of the Term. During the Term, Evolve agreed to purchase all of its
requirements for the Product on an exclusive basis from the Company.
The Product is designed to strengthen and rehabilitate the lower back
and adjacent areas of the body. Under the terms of the Agreement, Evolve will
own all right, title, and interest in and to the Product, and will market the
Product under its own trademarks, service marks, symbols or trade names.
On December 5, 2006, the Company announced that it had received the
first purchase order from Evolve for more than $54,000 of the Product. The
Product will be manufactured in China by the Company's Asia-based subsidiary,
CirTran Asia, and the Company anticipates that the Products will ship under this
first purchase order to the United States during January 2007. Once Evolve has
approved the first production run of the Product, the Company and Evolve will
confirm the price per unit.
New Director
As noted above, on February 1, 2007, Fadi Nora was appointed as a
director of the Company.
-26-
ANNUAL REPORT
Copies of the Company's Annual Report on Form 10-KSB (including
financial statements and financial statement schedules) for the year ended
December 31, 2005, filed with the Securities and Exchange Commission may be
obtained without charge by writing to the Company - Attention: Richard Ferrone,
4125 South 6000 West, West Valley City, Utah 84128. A request for a copy of the
Company's Annual Report on Form 10-KSB must set forth a good-faith
representation that the requesting party was either a holder of record or a
beneficial owner of common stock of the Company on March 16, 2007. Exhibits to
the Form 10-K, if any, will be mailed upon similar request and payment of
specified fees to cover the costs of copying and mailing such materials.
----------------------------------------
By Order of the Board of Directors
/s/ Iehab Hawatmeh
Iehab Hawatmeh
President and Director
West Valley City, Utah
March 29, 2007
-27-
EXHIBIT 1
ARTICLES OF AMENDMENT FOR ARTICLES OF INCORPORATION
CERTIFICATE OF AMENDMENT
Certificate of Amendment to Articles of Incorporation
-----------------------------------------------------
For Nevada Profit Corporations
------------------------------
(Pursuant to NRS 78.385 and 78.390 - After Issuance of Stock)
-Remit in Duplicate-
1. Name of Corporation: CirTran Corporation.
2. The articles have been amended as follows (provide article numbers,
if available):
The Articles of Incorporation are to be amended by striking out the
first paragraph of Article IV, as amended to date, in its entirety, and
inserting a new first paragraph of Article IV reading as follows:
ARTICLE IV
CAPITALIZATION
The aggregate number of shares which this Corporation shall have
authority to issue is 1,500,000,000 Common Shares having a par value of
$0.001 per share. Each share of stock shall entitle the holder thereof
to one (1) vote on each matter submitted to a vote at a meeting of the
shareholders. All stock of the Corporation shall be of the same class
and shall have the same rights and preferences. The capital stock of
the Corporation shall be issued as fully paid, and the private property
of the shareholders shall not be liable for the debts, obligations or
liabilities of the Corporation. Fully paid stock of this Corporation
shall not be liable to any further call of assessment. Effective as of
the time at which this Certificate of Amendment to Articles of
Incorporation (the "Amended Articles") becomes effective (the
"Effective Date"), all outstanding shares of common stock of the
Corporation automatically shall be subdivided at the rate of 1.20
shares for one share (the "Forward Split") without the necessity of any
further action on the part of the holders thereof or the Corporation,
provided, however, that the Corporation shall, through its transfer
agent and as necessary, exchange certificates representing common stock
outstanding immediately prior to the Effective Date of the Forward
Split (the "Existing Common") into new certificates representing the
appropriate number of shares of common stock resulting from the
subdivision ("New Common").
3. The vote by which the stockholders holding shares in the corporation
entitling them to exercise at least a majority of the voting power, or such
greater proportion of the voting power as ay be required in the case of a vote
by classes or series, or as may be required by the provisions of the articles of
incorporation have voted in favor of the amendment is:________________________.*
4. Signatures (Required):
__________________________________ ____________________________________
President or Vice President and Secretary or Asst. Secretary
*If any proposed amendment would alter or change any preference or relative or
other right given to any class or series of outstanding shares, then the
amendment must be approved by the vote, in addition to the affirmative vote
otherwise required, of the holders of shares representing a majority of the
voting power of each class or series affected by the amendment regardless of
limitations or restrictions on the voting power thereof. IMPORTANT: Failure to
include any of the above information and remit the proper fees may cause this
filing to be rejected.
-28-
EXHIBIT 2
FORM OF PROXY
CirTran Corporation
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Iehab Hawatmeh as Proxy, with full power of
substitution, and hereby authorizes him to represent and vote, as designated
below, all shares of Common Stock of the Company held of record by the
undersigned at the Special Meeting of Shareholders to be held at the Company's
headquarters, located at 4125 South 6000 West, West Valley City, Utah 84128 on
Monday, April 30, 2007, at 10:00 a.m., M.D.T., or at any adjournment thereof.
1. To consider and act upon a proposed amendment to the Company's articles
of incorporation that would increase the authorized capital of the
Company to include 1,500,000,000 shares of Common Stock, par value
$.001 per share, and effectuate a 1.2 shares for 1 share forward stock
split.
FOR AGAINST ABSTAIN
/ / / / / /
2. In his discretion, the Proxy is authorized to vote upon such other
business as may properly come before the Special Meeting.
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY
THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED
FOR PROPOSAL 1 AND IN THE PROXY'S DISCRETION FOR PROPOSAL 2.
Please sign and date this proxy where shown below and return it promptly:
Date: _____________________________________, 2007
Signed:
SIGNATURE(S)
PLEASE SIGN ABOVE EXACTLY AS THE SHARES ARE ISSUED. WHEN SHARES ARE HELD BY
JOINT TENANTS, BOTH SHOULD SIGN. WHEN SIGNING AS ATTORNEY, AS EXECUTOR,
ADMINISTRATOR, TRUSTEE OR GUARDIAN, PLEASE GIVE FULL TITLE AS SUCH. IF A
CORPORATION, PLEASE SIGN IN FULL CORPORATE NAME BY PRESIDENT OR OTHER AUTHORIZED
OFFICER. IF A PARTNERSHIP, PLEASE SIGN IN PARTNERSHIP NAME BY AUTHORIZED PERSON.
-29-
--------------------------------------------------------------------------------